Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Dumas

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The American Journal of Medicine|March 30, 1984
A preparation of modified immune serum globulin (human) suitable for intravenous administration. Further characterization and comparison with pepsin-treated intravenous gamma globulinD D Schroeder, M L Dumas
Archives Francaises De Pediatrie|May 1, 1991
[Transitory acute kidney insufficiency and insulin-dependent after treatment of kala-azar with pentamidine and N-methylglucamine antimony]D Morin, M L Dumas, H Valette, et al.
The Journal of Biological Chemistry|June 10, 1978
Characterization of human angiotensinogenD A Tewksbury, W L Frome, M L Dumas
Archives Francaises De Pediatrie|February 1, 1982
[Membranous glomerulonephritis in two brothers associated in one with tubulo-interstitial disease, Fanconi syndrome and anti-TBM antibodies (author's transl)]R Dumas, M L Dumas, P Baldet, et al.
Circulation Research|October 1, 1977
Purification of human angiotensinogenD A Tewksbury, M R Premeau, M L Dumas, et al.
Biologicals : Journal of the International Association of Biological Standardization|March 1, 1994
Inactivation of hepatitis C virus in low pH intravenous immunoglobulinR E Louie, C J Galloway, M L Dumas, et al.
Vox Sanguinis|January 1, 1984
Detection of IgG-associated determinants in reduced and alkylated preparations of human IgG3 by monoclonal antibodiesA M Brown, M L Dumas, C B Reimer, et al.
European Journal of Immunology|November 1, 1992
Anti-tumor necrosis factor receptor and tumor necrosis factor agonist activity by an anti-idiotypic antibodyC J Galloway, M S Madanat, T Sarr, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The American Journal of Medicine|March 30, 1984
A preparation of modified immune serum globulin (human) suitable for intravenous administration. Further characterization and comparison with pepsin-treated intravenous gamma globulinD D Schroeder, M L Dumas
Archives Francaises De Pediatrie|May 1, 1991
[Transitory acute kidney insufficiency and insulin-dependent after treatment of kala-azar with pentamidine and N-methylglucamine antimony]D Morin, M L Dumas, H Valette, et al.
The Journal of Biological Chemistry|June 10, 1978
Characterization of human angiotensinogenD A Tewksbury, W L Frome, M L Dumas
Archives Francaises De Pediatrie|February 1, 1982
[Membranous glomerulonephritis in two brothers associated in one with tubulo-interstitial disease, Fanconi syndrome and anti-TBM antibodies (author's transl)]R Dumas, M L Dumas, P Baldet, et al.
Circulation Research|October 1, 1977
Purification of human angiotensinogenD A Tewksbury, M R Premeau, M L Dumas, et al.
Biologicals : Journal of the International Association of Biological Standardization|March 1, 1994
Inactivation of hepatitis C virus in low pH intravenous immunoglobulinR E Louie, C J Galloway, M L Dumas, et al.
Vox Sanguinis|January 1, 1984
Detection of IgG-associated determinants in reduced and alkylated preparations of human IgG3 by monoclonal antibodiesA M Brown, M L Dumas, C B Reimer, et al.
European Journal of Immunology|November 1, 1992
Anti-tumor necrosis factor receptor and tumor necrosis factor agonist activity by an anti-idiotypic antibodyC J Galloway, M S Madanat, T Sarr, et al.
Pageof 1